2215 Systemic activation of the VEGF receptor KDR/FLK-1 leads to angiogenesis

نویسندگان

  • C. Favard
  • N. Ortega
  • Y. Pouliquen
  • M.-M. Ruchoux
  • J. Plouet
چکیده

SYSTEMIC ACTIVATION OF THE VEGF RECEPTOR KDWFLK-1 LEADS TO ANGIOGENESIS. FAVARD C.1, ORTEGA N.2, POULIQUEN Y.‘., RUCHOUX M-h@, and PLOUET J.2 1 Hotel Dieu, Paris, (France) 2 LBME CNRS, Toulouse, (France) 3Hopital B, Lille, (France) PurDose, Vascular endothelial growth factor (VEGF) stimulates retinal capillary endothelial cell proliferation through the activation of its receptor KDR. To investigate the role of VEGF in the onset of neovascularization we designed circulating agonists of KDR and looked at their angiogenic potential. Method. Anti-VEGF idiotypic antibodies were elicited in

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.

Endothelial cells (ECs) are the critical cellular element responsible for postnatal angiogenesis. Vascular endothelial growth factor (VEGF) stimulates angiogenesis via the activation of kinase insert domain-containing receptor/fetal liver kinase-1 (KDR/Flk-1) in ECs. In addition, transactivation of KDR/Flk-1 by the bradykinin (BK) B2 receptor induces the activation of endothelial nitric oxide s...

متن کامل

Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signaling.

Interaction between vascular endothelial growth factor (VEGF) and its cognate receptors, KDR/Flk-1 and Flt-1, of vascular endothelial cells is expected to induce an angiogenesis "switch" in tumors and other angiogenesis-associated diseases. SU5416, a selective inhibitor of the KDR/Flk-1 tyrosine kinase, is known to be a potent inhibitor of tumor angiogenesis. In this study, we first observed th...

متن کامل

Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications.

Vascular endothelial growth factor (VEGF)-Flk-1/KDR tyrosine kinase signaling pathway plays a pivotal role in tumor angiogenesis. Targeting this angiogenic signaling pathway presents a promising alternative for the treatment of neoplasms. However, recent experimental and clinical studies have suggested that VEGF-Flk-1/KDR activity is unevenly distributed throughout the tumor microvasculature. T...

متن کامل

Human/mouse cross-reactive anti-VEGF receptor 2 recombinant antibodies selected from an immune b9 allotype rabbit antibody library.

Vascular endothelial growth factor (VEGF) and its receptors have been implicated in promoting solid tumor growth and metastasis via stimulating tumor-associated angiogenesis. Models of murine tumor angiogenesis and receptor-specific antibodies are required to evaluate roles of VEGF receptors in mouse models of human cancer. Human VEGFR2 (also known as KDR) and murine VEGFR2 (or Flk-1) share 85%...

متن کامل

Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia.

BACKGROUND In a pathological setting, tumor necrosis factor (TNF)-alpha inhibits the proliferative response of endothelial cells through inactivation of receptors for vascular endothelial growth factor (VEGF). Soluble TNF-alpha receptor 1 (sTNFR1) is an extracellular domain of TNFR1 and an antagonist to TNF-alpha. In the present study, we examined the effect of sTNFR1 expression plasmid on rece...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Vision Research

دوره 35  شماره 

صفحات  -

تاریخ انتشار 1995